Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (441-450 of 663) with videos related to

Pageof 67
Sort By:
British Medical Journal (Clinical Research Ed.)|November 9, 1985
Severe hypotension after first dose of enalapril in heart failureJ G Cleland, H J Dargie, H McAlpine, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritisF Bochner, G G Graham, A Polverino, et al.
Circulation|September 29, 1999
Impaired pulmonary diffusion during exercise in patients with chronic heart failureA A Smith, P J Cowburn, M E Parker, et al.
BMC Geriatrics|May 3, 2013
Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literatureAnthony M Villani, Maria Crotty, Leslie G Cleland, et al.
Archives of Cardiovascular Diseases|November 13, 2021
No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trialJoão Pedro Ferreira, Nicolas Girerd, Hans-Peter Brunner-La Rocca, et al.
Arthritis Research & Therapy|July 13, 2012
Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritisMichael D Wiese, Matthew Schnabl, Catherine O'Doherty, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
European Journal of Heart Failure|August 10, 2000
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigatorsJ G Cleland, M Tendera, J Adamus, et al.
ESC Heart Failure|August 24, 2017
Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-studyAdam K McDiarmid, Huan Loh, Nikolay Nikitin, et al.
Pharmacoeconomics|September 1, 2006
Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharingJohn H Wlodarczyk, Leslie G Cleland, Anne M Keogh, et al.
Pageof 67

Showing results (441-450 of 663) with videos related to

Sort By:
Pageof 67
British Medical Journal (Clinical Research Ed.)|November 9, 1985
Severe hypotension after first dose of enalapril in heart failureJ G Cleland, H J Dargie, H McAlpine, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritisF Bochner, G G Graham, A Polverino, et al.
Circulation|September 29, 1999
Impaired pulmonary diffusion during exercise in patients with chronic heart failureA A Smith, P J Cowburn, M E Parker, et al.
BMC Geriatrics|May 3, 2013
Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literatureAnthony M Villani, Maria Crotty, Leslie G Cleland, et al.
Archives of Cardiovascular Diseases|November 13, 2021
No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trialJoão Pedro Ferreira, Nicolas Girerd, Hans-Peter Brunner-La Rocca, et al.
Arthritis Research & Therapy|July 13, 2012
Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritisMichael D Wiese, Matthew Schnabl, Catherine O'Doherty, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
European Journal of Heart Failure|August 10, 2000
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigatorsJ G Cleland, M Tendera, J Adamus, et al.
ESC Heart Failure|August 24, 2017
Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-studyAdam K McDiarmid, Huan Loh, Nikolay Nikitin, et al.
Pharmacoeconomics|September 1, 2006
Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharingJohn H Wlodarczyk, Leslie G Cleland, Anne M Keogh, et al.
Pageof 67